| 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | 2014 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 78.26 | 181.02 | 161.28 | 155.74 | 167.03 |
| Other Income | 53.92 | 13.72 | 2.94 | 3.03 | 10 |
| Stock Adjustments | 0 | 0 | 0 | 0 | 0 |
| Total Income | 132.18 | 194.74 | 164.22 | 158.77 | 177.03 |
| EXPENDITURE : | |||||
| Raw Materials | 26.81 | 25.16 | 18.87 | 10.1 | 8.01 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 4.93 | 4.67 | 4.49 | 4.78 | 3.95 |
| Other Manufacturing Expenses | 126.22 | 144.88 | 127.48 | 119.18 | 8.44 |
| Employee Cost | 100.92 | 84.3 | 56.6 | 45.79 | 40.4 |
| Selling and Administration Expenses | 59.94 | 39.64 | 11.96 | 8.04 | 71.45 |
| Miscellaneous Expenses | 2.05 | 5.06 | 5.08 | 2.94 | 1.29 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -188.69 | -108.98 | -60.25 | -32.06 | 43.5 |
| Interest and Financial Charges | 0.12 | 1.82 | 2.16 | 0.22 | 5.6 |
| Profit before Depreciation and Tax | -188.81 | -110.8 | -62.41 | -32.28 | 37.9 |
| Depreciation | 8.18 | 8.24 | 7.58 | 7.24 | 3.57 |
| Profit Before Tax | -197 | -119.04 | -69.99 | -39.52 | 34.32 |
| Tax | 0 | 0 | 0 | 0 | 4 |
| Profit After Tax | -197 | -119.04 | -69.99 | -39.52 | 30.32 |
| Adjustment below Net Profit | -1.43 | -0.46 | 0 | 0 | 0 |
| P and L Balance brought forward | -342.48 | -222.98 | -152.99 | -113.47 | -143.79 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | -540.91 | -342.48 | -222.98 | -152.99 | -113.47 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 | 1.28 |
| Book Value | 3.71 | 6.41 | 1.26 | 4.22 | 5.89 |
| Extraordinary Items | 52.98 | -0.01 | -0.08 | 0.2 | 4.08 |
| 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | 2014 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 25.09 | 24.69 | 23.67 | 23.67 | 23.67 |
| Reserves and Surplus | 159.63 | 133.47 | 8.13 | 76.13 | 115.63 |
| Total Shareholders Funds | 184.72 | 158.16 | 31.8 | 99.8 | 139.3 |
| Secured Loans | 0 | 0 | 1.28 | 0.4 | 0.22 |
| Unsecured Loans | 8.63 | 7.32 | 57.77 | 6.27 | 6.6 |
| Total Debt | 8.63 | 7.32 | 59.05 | 6.67 | 6.82 |
| Total Liabilities | 193.35 | 165.48 | 90.85 | 106.47 | 146.12 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 67.17 | 77.28 | 106.82 | 96.38 | 86.98 |
| Less: Accum. Depreciation | 15.44 | 8.12 | 36.86 | 29.58 | 22.49 |
| Net Block | 51.73 | 69.16 | 69.96 | 66.8 | 64.49 |
| Capital Work in Progress | 3.27 | 1.47 | 0.87 | 0.02 | 0.76 |
| Investments | 107.57 | 9.65 | 0 | 0 | 6.5 |
| Current Assets, Loans and Advances | |||||
| Inventories | 0 | 0 | 0 | 0 | 0 |
| Sundry Debtors | 17.56 | 38.9 | 9.16 | 19.89 | 28 |
| Cash and Bank Balance | 1.32 | 70.31 | 12.75 | 17.34 | 6.56 |
| Loans and Advances | 141.7 | 106.59 | 91.81 | 59.24 | 96.99 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 125.71 | 127.25 | 91.58 | 56.06 | 56.53 |
| Provisions | 4.1 | 3.35 | 2.12 | 0.77 | 0.64 |
| Net Current Assets | 30.77 | 85.2 | 20.02 | 39.64 | 74.38 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 193.34 | 165.48 | 90.85 | 106.46 | 146.13 |
| Contingent Liabilities | 83.14 | 52.68 | 20.3 | 20.37 | 4.3 |
If I had made LUMPSUM investment of ₹ 1,00,000
in SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
